BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 38059453)

  • 1. Serum IgE anti-dsDNA autoantibodies in patients with proliferative lupus nephritis are associated with tubulointerstitial inflammation.
    Chen L; Yuan M; Tan Y; Zhao M
    Ren Fail; 2023; 45(2):2273981. PubMed ID: 38059453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-dsDNA IgE: a potential non-invasive test for prediction of lupus nephritis relapse.
    Himbert M; Jourde-Chiche N; Chapart L; Charles N; Baumstarck K; Daugas E
    RMD Open; 2024 Jun; 10(2):. PubMed ID: 38942591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-dsDNA, anti-nucleosome, anti-C1q, and anti-histone antibodies as markers of active lupus nephritis and systemic lupus erythematosus disease activity.
    Shang X; Ren L; Sun G; Yu T; Yao Y; Wang L; Liu F; Zhang L; He X; Liu M
    Immun Inflamm Dis; 2021 Jun; 9(2):407-418. PubMed ID: 33470559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between anti-dsDNA, anti-nucleosome and anti-alpha-actinin antibodies and markers of renal disease in patients with lupus nephritis: a prospective longitudinal study.
    Manson JJ; Ma A; Rogers P; Mason LJ; Berden JH; van der Vlag J; D'Cruz DP; Isenberg DA; Rahman A
    Arthritis Res Ther; 2009 Oct; 11(5):R154. PubMed ID: 19828047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoantibodies Targeting Ficolin-2 in Systemic Lupus Erythematosus Patients With Active Nephritis.
    Colliard S; Jourde-Chiche N; Clavarino G; Sarrot-Reynauld F; Gout E; Deroux A; Fougere M; Bardin N; Bouillet L; Cesbron JY; Thielens NM; Dumestre-Pérard C
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1263-1268. PubMed ID: 29045037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-DFS70 Antibodies Are Associated With Proliferative Lupus Nephritis and Renal Pathological Activity.
    Chen D; Zhao L; Dai Y; Du F; Li E; Niu X; Wang Z; Zheng B; Lu L
    Front Immunol; 2022; 13():810639. PubMed ID: 35185903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis.
    Dieker J; Schlumberger W; McHugh N; Hamann P; van der Vlag J; Berden JH
    Mol Immunol; 2015 Nov; 68(1):20-4. PubMed ID: 26597199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantigen microarrays reveal autoantibodies associated with proliferative nephritis and active disease in pediatric systemic lupus erythematosus.
    Haddon DJ; Diep VK; Price JV; Limb C; Utz PJ; Balboni I
    Arthritis Res Ther; 2015 Jun; 17(1):162. PubMed ID: 26081107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoreactive IgE is prevalent in systemic lupus erythematosus and is associated with increased disease activity and nephritis.
    Dema B; Pellefigues C; Hasni S; Gault N; Jiang C; Ricks TK; Bonelli MM; Scheffel J; Sacré K; Jablonski M; Gobert D; Papo T; Daugas E; Illei G; Charles N; Rivera J
    PLoS One; 2014; 9(2):e90424. PubMed ID: 24587356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-dsDNA antibodies in Brazilian patients of mainly African descent with systemic lupus erythematosus: lack of association with lupus nephritis.
    Atta AM; Pereira MM; Santiago M; Sousa-Atta ML
    Clin Rheumatol; 2009 Jun; 28(6):693-7. PubMed ID: 19283331
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison between multiplex assays for autoantibody detection in systemic lupus erythematosus.
    Hanly JG; Su L; Farewell V; Fritzler MJ
    J Immunol Methods; 2010 Jun; 358(1-2):75-80. PubMed ID: 20438730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.
    Pradhan VD; Patwardhan MM; Ghosh K
    Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-dsDNA, anti-Sm antibodies, and the lupus anticoagulant: significant factors associated with lupus nephritis.
    Alba P; Bento L; Cuadrado MJ; Karim Y; Tungekar MF; Abbs I; Khamashta MA; D'Cruz D; Hughes GR
    Ann Rheum Dis; 2003 Jun; 62(6):556-60. PubMed ID: 12759294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High frequency of concurrent anti-C1q and anti-dsDNA but not anti-C3b antibodies in patients with Lupus Nephritis.
    Kianmehr N; Khoshmirsafa M; Shekarabi M; Falak R; Haghighi A; Masoodian M; Seif F; Omidi F; Shirani F; Dadfar N
    J Immunoassay Immunochem; 2021 Jul; 42(4):406-423. PubMed ID: 33788670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonrenal and renal activity of systemic lupus erythematosus: a comparison of two anti-C1q and five anti-dsDNA assays and complement C3 and C4.
    Julkunen H; Ekblom-Kullberg S; Miettinen A
    Rheumatol Int; 2012 Aug; 32(8):2445-51. PubMed ID: 21706294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A critical view on autoantibodies in lupus nephritis: Concrete knowledge based on evidence.
    Bruschi M; Angeletti A; Prunotto M; Meroni PL; Ghiggeri GM; ; Moroni G; Sinico RA; Franceschini F; Fredi M; Vaglio A; Cavalli A; Scapozza L; Patel JJ; Tan JC; Lo KC; Cavagna L; Petretto A; Pratesi F; Migliorini P; Locatelli F; Pazzola G; Pesce G; Giannese D; Manfredi A; Ramirez GA; Esposito P; Murdaca G; Negrini S; Bui F; Trezzi B; Emmi G; Cavazzana I; Binda V; Fenaroli P; Pisan I; Montecucco C; Santoro D; Scolari F; Mescia F; Volpi S; Mosca M; Tincani A; Ravelli A; Murtas C; Candiano G; Caridi G; La Porta E; Verrina E
    Autoimmun Rev; 2024 May; 23(5):103535. PubMed ID: 38552995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity.
    Emad G; Al-Barshomy SM
    Saudi J Kidney Dis Transpl; 2020; 31(2):342-352. PubMed ID: 32394906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and functional consequences of anti-properdin autoantibodies in patients with lupus nephritis.
    Radanova M; Mihaylova G; Ivanova D; Daugan M; Lazarov V; Roumenina L; Vasilev V
    Clin Exp Immunol; 2020 Aug; 201(2):135-144. PubMed ID: 32306375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-neutrophil cytoplasmic antibodies (ANCA) in systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies.
    Pradhan VD; Badakere SS; Bichile LS; Almeida AF
    J Assoc Physicians India; 2004 Jul; 52():533-7. PubMed ID: 15645975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.